DUSA Files Form S-3 Shelf Registration Statement

WILMINGTON, MASSACHUSETTS--(Marketwire - May 16, 2008) - DUSA Pharmaceuticals, Inc.(R) (NASDAQ GM:DUSA), a dermatology company that is developing and marketing Levulan(R) photodynamic therapy (PDT) and other products targeting patients with common skin conditions, today announced the filing of a... [read full story]                    

Add Comment
There are also 3 related articles
View all news articles about*:
*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies